Therapeutics and Targets

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 139 total displayed.

Most recent content

Reviews
Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway

Toru Akiyama, Crispin R. Dass, and Peter F.M. Choong
Mol. Cancer Ther. 2008; 7: 3461-3469. [Abstract] [Full text] [PDF]  

Past content

Reviews
Structural and Functional Basis for Therapeutic Modulation of p53 Signaling

Emily A. Bassett, Wenge Wang, Farzan Rastinejad, and Wafik S. El-Deiry
Clin. Cancer Res. 2008; 14: 6376-6386. [Abstract] [Full text] [PDF]  

Review
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Scott M. Wilhelm, Lila Adnane, Philippa Newell, Augusto Villanueva, Josep M. Llovet, and Mark Lynch
Mol. Cancer Ther. 2008; 7: 3129-3140. [Abstract] [Full text] [PDF]  

CCR Special Focus
The Translational Research Working Group Developmental Pathway for Image-Based Assessment Modalities

Gary S. Dorfman, Daniel C. Sullivan, Mitchell D. Schnall, Lynn M. Matrisian for the Translational Research Working Group
Clin. Cancer Res. 2008; 14: 5678-5684. [Abstract] [Full text] [PDF]  

CCR Special Focus
The Translational Research Working Group Developmental Pathway for Anticancer Agents (Drugs or Biologics)

Richard L. Schilsky, Gary Gordon, Tona M. Gilmer, Sara A. Courtneidge, Lynn M. Matrisian, Oren Grad, William G. Nelson on behalf of the Translational Research Working Group
Clin. Cancer Res. 2008; 14: 5685-5691. [Abstract] [Full text] [PDF]  

Review
Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials

Jordi Rodon, Victoria DeSantos, Robert Jean Ferry, Jr., and Razelle Kurzrock
Mol. Cancer Ther. 2008; 7: 2575-2588. [Abstract] [Full text] [PDF]  

Reviews
iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy

Helen S. Bell and Kevin M. Ryan
Cancer Res. 2008; 68: 4959-4962. [Abstract] [Full text] [PDF]  

Subject Reviews
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective

Chih-Pin Chuu, Rou-Yu Chen, John L. Barkinge, Mark F. Ciaccio, and Richard B. Jones
Mol. Cancer Res. 2008; 6: 885-891. [Abstract] [Full text] [PDF]  

Subject Reviews
Zinc 2-Glycoprotein: A Multidisciplinary Protein

Md. Imtaiyaz Hassan, Abdul Waheed, Savita Yadav, Tej P. Singh, and Faizan Ahmad
Mol. Cancer Res. 2008; 6: 892-906. [Abstract] [Full text] [PDF]  

Review
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies

Jorge A. Garcia and David Danielpour
Mol. Cancer Ther. 2008; 7: 1347-1354. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14